Amino Acid Prodrugs of Antitumour Benzothiazoles
Author Information
Author(s): Bradshaw T D, Chua M-S, Browne H L, Trapani V, Sausville E A, Stevens M F G
Primary Institution: University of Nottingham
Hypothesis
Can amino acid prodrugs of 2-(4-amino-3-methylphenyl)benzothiazoles retain antitumour activity while improving solubility and stability?
Conclusion
Amino acid prodrugs of 2-(4-amino-3-methylphenyl)benzothiazoles are effective and retain their selective antitumour properties.
Supporting Evidence
- The prodrugs were shown to be rapidly converted back to their active forms in sensitive cancer cells.
- The study demonstrated that the prodrugs maintained selective antitumour activity against specific cancer cell lines.
- CYP1A1 activity was selectively induced in sensitive carcinoma cells, supporting the mechanism of action.
Takeaway
Scientists created special versions of a cancer-fighting drug that dissolve better in water and still work well against certain cancer cells.
Methodology
The study involved growth inhibitory assays and metabolism studies using various human cancer cell lines.
Limitations
The prodrugs may have reduced potency compared to their parent compounds in some sensitive cell lines.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website